CD8A and leukemia: These activated, nonspecific CD4+ T cells can acquire the leukemia antigen specificity and induce the stimulatory effect for leukemia antigen-specific CD8+ CTL responses after incubation with EXO derived from the leukemia cells in peripheral blood or bone marrow of a patient and thus be used as alternative EXO-based vaccines.